For research use only. Not for therapeutic Use.
Moyukamycin(CAT: I032712) is a secondary metabolite produced by certain bacterial strains, often studied for its potential antimicrobial and antitumor properties. Its unique chemical structure and biological activity make it a valuable tool in natural product research, supporting investigations into novel therapeutic agents. Moyukamycin is particularly relevant in microbial and pharmaceutical research, where it aids in exploring mechanisms of action, microbial resistance, and potential applications in treating infections or cancer. Its discovery highlights the therapeutic potential of microbial metabolites in drug development.
Catalog Number | I032712 |
CAS Number | 96827-80-4 |
Synonyms | Moyukamycin |
Molecular Formula | C47H76O13 |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (2S,3E,6E,8S)-8-((2S,2'R,4'S,7R,7'R,8R,9S,10'S)-9-hydroxy-2'-((2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyltetrahydro-2H-pyran-2-yl)-10'-((((2R,5S,6R)-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-2,4',8-trimethyl-1,1',6,6'-tetraoxa[2,7'-bispiro[4.5]decan]-7-yl)-2,4,6-trimethyl-5-oxonona-3,6-dienoic acid |
InChI | InChI=1S/C47H76O13/c1-25(40(49)26(2)20-29(5)43(50)51)19-27(3)41-32(8)35(48)23-46(59-41)18-17-44(10,60-46)38-15-13-34(24-54-39-16-14-36(53-12)33(9)55-39)47(57-38)31(7)22-37(56-47)42-28(4)21-30(6)45(11,52)58-42/h19-20,27-39,41-42,48,52H,13-18,21-24H2,1-12H3,(H,50,51)/b25-19+,26-20+/t27-,28-,29-,30+,31-,32+,33+,34-,35-,36-,37+,38+,39+,41+,42-,44-,45-,46?,47?/m0/s1 |
InChIKey | FSDVMXQBHNGLNZ-KDPRXSLLSA-N |
SMILES | CO[C@H]1CC[C@@H](O[C@@H]1C)OC[C@@H]2CC[C@H]([C@@]3(CCC4(O3)C[C@@H]([C@H]([C@@H]([C@H](/C=C(C(/C(C)=C/[C@@H](C(O)=O)C)=O)C)C)O4)C)O)C)OC25O[C@@H]([C@H]6O[C@](O)([C@@H](C[C@@H]6C)C)C)C[C@@H]5C |